BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 17506873)

  • 1. Effect of induction agent on vasopressor and steroid use, and outcome in patients with septic shock.
    Ray DC; McKeown DW
    Crit Care; 2007; 11(3):R56. PubMed ID: 17506873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction drug and outcome of patients admitted to the intensive care unit after emergency laparotomy.
    Ray DC; Hay AW; McKeown DW
    Eur J Anaesthesiol; 2010 May; 27(5):481-5. PubMed ID: 19887951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid sequence induction in the emergency department: induction drug and outcome of patients admitted to the intensive care unit.
    Baird CR; Hay AW; McKeown DW; Ray DC
    Emerg Med J; 2009 Aug; 26(8):576-9. PubMed ID: 19625554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-dose etomidate is not associated with increased mortality in ICU patients with sepsis: analysis of a large electronic ICU database.
    McPhee LC; Badawi O; Fraser GL; Lerwick PA; Riker RR; Zuckerman IH; Franey C; Seder DB
    Crit Care Med; 2013 Mar; 41(3):774-83. PubMed ID: 23318491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective observational study of the effect of etomidate on septic patient mortality and length of stay.
    Tekwani KL; Watts HF; Rzechula KH; Sweis RT; Kulstad EB
    Acad Emerg Med; 2009 Jan; 16(1):11-4. PubMed ID: 19055676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ketamine/propofol admixture (ketofol) at induction in the critically ill against etomidate (KEEP PACE trial): study protocol for a randomized controlled trial.
    Smischney NJ; Hoskote SS; Gallo de Moraes A; Racedo Africano CJ; Carrera PM; Tedja R; Pannu JK; Hassebroek EC; Reddy DR; Hinds RF; Thakur L
    Trials; 2015 Apr; 16():177. PubMed ID: 25909406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should etomidate be used for rapid-sequence intubation induction in critically ill septic patients?
    Fengler BT
    Am J Emerg Med; 2008 Feb; 26(2):229-32. PubMed ID: 18272107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anesthetic induction with etomidate, rather than propofol, is associated with increased 30-day mortality and cardiovascular morbidity after noncardiac surgery.
    Komatsu R; You J; Mascha EJ; Sessler DI; Kasuya Y; Turan A
    Anesth Analg; 2013 Dec; 117(6):1329-37. PubMed ID: 24257383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of etomidate in severe sepsis and septic shock.
    Dmello D; Taylor S; O'Brien J; Matuschak GM
    Chest; 2010 Dec; 138(6):1327-32. PubMed ID: 20651024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adrenal exhaustion in septic patients with vasopressor dependency.
    Guzman JA; Guzman CB
    J Crit Care; 2007 Dec; 22(4):319-23. PubMed ID: 18086403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of corticosteroids on arginine vasopressin-containing vasopressor therapy for septic shock: a case control study.
    Bauer SR; Lam SW; Cha SS; Oyen LJ
    J Crit Care; 2008 Dec; 23(4):500-6. PubMed ID: 19056013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of vasopressor agent in septic shock mortality. Results from the Portuguese Community-Acquired Sepsis Study (SACiUCI study).
    Póvoa PR; Carneiro AH; Ribeiro OS; Pereira AC;
    Crit Care Med; 2009 Feb; 37(2):410-6. PubMed ID: 19114885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Non-Comparative Prospective Pilot Study of Ketamine for Sedation in Adult Septic Shock.
    Reese JM; Sullivan VF; Boyer NL; Mount CA
    Mil Med; 2018 Nov; 183(11-12):e409-e413. PubMed ID: 29800375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of etomidate on vasopressor use in patients with sepsis or severe sepsis: a propensity-matched analysis.
    Alday NJ; Jones GM; Kimmons LA; Phillips GS; McCallister JW; Doepker BA
    J Crit Care; 2014 Aug; 29(4):517-22. PubMed ID: 24629575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for mortality in septic patients who received etomidate.
    Rech MA; Bennett S; Chaney W; Sterk E
    Am J Emerg Med; 2015 Oct; 33(10):1340-3. PubMed ID: 26321168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized trial of anesthetic induction agents in patients with coronary artery disease and left ventricular dysfunction.
    Singh R; Choudhury M; Kapoor PM; Kiran U
    Ann Card Anaesth; 2010; 13(3):217-23. PubMed ID: 20826962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute adrenal insufficiency after a single dose of etomidate.
    Lundy JB; Slane ML; Frizzi JD
    J Intensive Care Med; 2007; 22(2):111-7. PubMed ID: 17456730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anaesthetic induction with etomidate in cardiac surgery: A randomised controlled trial.
    Basciani RM; Rindlisbacher A; Begert E; Brander L; Jakob SM; Etter R; Carrel T; Eberle B
    Eur J Anaesthesiol; 2016 Jun; 33(6):417-24. PubMed ID: 26914224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anesthesia and electroconvulsive therapy: a retrospective study comparing etomidate and propofol.
    Patel AS; Gorst-Unsworth C; Venn RM; Kelley K; Jacob Y
    J ECT; 2006 Sep; 22(3):179-83. PubMed ID: 16957533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis of corticosteroid insufficiency in Thai patients with septic shock.
    Ratanarat R; Promsin P; Srivijitkamol A; Leemingsawat C; Permpikul C
    J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S187-95. PubMed ID: 20364574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.